Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Bergami

Showing results (1-10 of 29) with videos related to

Pageof 3
Sort By:
Environmental Toxicology and Pharmacology|July 26, 2011
The effect of the spin trapping agent α-phenyl-n-tert-butyl nitrone on dexfenfluramine-induced serotonin depletion in rat brainA Bergami, C Fracasso, S Caccia
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1995
Oral kinetics of dexfenfluramine and dexnorfenfluramine in non-human primatesS Caccia, A Bergami, C Fracasso, et al.
Psychopharmacology|March 1, 1995
Effect of d-fenfluramine on the indole contents of the rat brain after treatment with different inducers of cytochrome P450 isoenzymesM Anelli, C Fracasso, A Bergami, et al.
Neuropharmacology|December 1, 1995
Depletion and time-course of recovery of brain serotonin after repeated subcutaneous dexfenfluramine in the mouse. A comparison with the ratC Fracasso, G Guiso, S Confalonieri, et al.
Pharmacology, Biochemistry, and Behavior|August 1, 1997
Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetineS Caccia, S Confalonieri, A Bergami, et al.
Neuroscience Letters|November 15, 1996
Effects of repeated oral doses of dexnorfenfluramine on 5-HT levels and 5-HT uptake sites in rat brainM Gobbi, A Bergami, C Caltavuturo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 24, 2001
Immunological markers in multiple sclerosisM Gironi, A Bergami, E Brambilla, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1996
In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the ratT Mennini, C Fracasso, A Cagnotto, et al.
Journal of Neuroimmunology|November 7, 2000
Interferon-beta treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-gamma and interleukin-4R Furlan, A Bergami, R Lang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 1998
A gene therapy approach to treat demyelinating diseases using non-replicative herpetic vectors engineered to produce cytokinesG Martino, R Furlan, F Galbiati, et al.
Pageof 3

Showing results (1-10 of 29) with videos related to

Sort By:
Pageof 3
Environmental Toxicology and Pharmacology|July 26, 2011
The effect of the spin trapping agent α-phenyl-n-tert-butyl nitrone on dexfenfluramine-induced serotonin depletion in rat brainA Bergami, C Fracasso, S Caccia
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|November 1, 1995
Oral kinetics of dexfenfluramine and dexnorfenfluramine in non-human primatesS Caccia, A Bergami, C Fracasso, et al.
Psychopharmacology|March 1, 1995
Effect of d-fenfluramine on the indole contents of the rat brain after treatment with different inducers of cytochrome P450 isoenzymesM Anelli, C Fracasso, A Bergami, et al.
Neuropharmacology|December 1, 1995
Depletion and time-course of recovery of brain serotonin after repeated subcutaneous dexfenfluramine in the mouse. A comparison with the ratC Fracasso, G Guiso, S Confalonieri, et al.
Pharmacology, Biochemistry, and Behavior|August 1, 1997
Neuropharmacological effects of low and high doses of repeated oral dexfenfluramine in rats: a comparison with fluoxetineS Caccia, S Confalonieri, A Bergami, et al.
Neuroscience Letters|November 15, 1996
Effects of repeated oral doses of dexnorfenfluramine on 5-HT levels and 5-HT uptake sites in rat brainM Gobbi, A Bergami, C Caltavuturo, et al.
Neurological Sciences : Official Journal of the Italian Neurological Society and of the Italian Society of Clinical Neurophysiology|February 24, 2001
Immunological markers in multiple sclerosisM Gironi, A Bergami, E Brambilla, et al.
Naunyn-Schmiedeberg'S Archives of Pharmacology|May 1, 1996
In vitro and in vivo effects of the anorectic agent dexfenfluramine on the central serotoninergic neuronal systems of non-human primates. A comparison with the ratT Mennini, C Fracasso, A Cagnotto, et al.
Journal of Neuroimmunology|November 7, 2000
Interferon-beta treatment in multiple sclerosis patients decreases the number of circulating T cells producing interferon-gamma and interleukin-4R Furlan, A Bergami, R Lang, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|October 8, 1998
A gene therapy approach to treat demyelinating diseases using non-replicative herpetic vectors engineered to produce cytokinesG Martino, R Furlan, F Galbiati, et al.
Pageof 3